Haruo Kuroboshi

569 total citations
22 papers, 429 citations indexed

About

Haruo Kuroboshi is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Immunology. According to data from OpenAlex, Haruo Kuroboshi has authored 22 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Obstetrics and Gynecology, 13 papers in Reproductive Medicine and 7 papers in Immunology. Recurrent topics in Haruo Kuroboshi's work include Endometrial and Cervical Cancer Treatments (9 papers), Uterine Myomas and Treatments (8 papers) and Endometriosis Research and Treatment (8 papers). Haruo Kuroboshi is often cited by papers focused on Endometrial and Cervical Cancer Treatments (9 papers), Uterine Myomas and Treatments (8 papers) and Endometriosis Research and Treatment (8 papers). Haruo Kuroboshi collaborates with scholars based in Japan, China and United States. Haruo Kuroboshi's co-authors include Jo Kitawaki, Tomoharu Okubo, Taisuke Mori, Hideo Honjo, Shinji Fushiki, Kotaro Kitaya, Takeshi Nakayama, Akemi Koshiba, Akira Fujishita and Khaleque Newaz Khan and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Fertility and Sterility and Gynecologic Oncology.

In The Last Decade

Haruo Kuroboshi

21 papers receiving 421 citations

Peers

Haruo Kuroboshi
Haruo Kuroboshi
Citations per year, relative to Haruo Kuroboshi Haruo Kuroboshi (= 1×) peers Kuniaki Nakayama

Countries citing papers authored by Haruo Kuroboshi

Since Specialization
Citations

This map shows the geographic impact of Haruo Kuroboshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruo Kuroboshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruo Kuroboshi more than expected).

Fields of papers citing papers by Haruo Kuroboshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruo Kuroboshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruo Kuroboshi. The network helps show where Haruo Kuroboshi may publish in the future.

Co-authorship network of co-authors of Haruo Kuroboshi

This figure shows the co-authorship network connecting the top 25 collaborators of Haruo Kuroboshi. A scholar is included among the top collaborators of Haruo Kuroboshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruo Kuroboshi. Haruo Kuroboshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Hisashi, Suguru Yamashita, Haruo Kuroboshi, et al.. (2024). Recurrent ischemic strokes and elevated CA125 levels in a patient with Meigs syndrome: A case report. Neurology and Clinical Neuroscience. 13(1). 63–65.
2.
Khan, Khaleque Newaz, Haruo Kuroboshi, Akemi Koshiba, et al.. (2023). Neonatal uterine bleeding: Risk factors and its association with endometriosis-related symptoms later in life. European Journal of Obstetrics & Gynecology and Reproductive Biology. 293. 146–155. 1 indexed citations
3.
Khan, Khaleque Newaz, Haruo Kuroboshi, Akemi Koshiba, et al.. (2023). Is neonatal uterine bleeding responsible for early-onset endometriosis?. Reproductive Biology and Endocrinology. 21(1). 56–56. 2 indexed citations
4.
Takeuchi, Satoshi, Haruo Kuroboshi, Taisuke Mori, et al.. (2020). Phase 1/2 study of concurrent chemo-radiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group. Chinese Journal of Cancer Research. 32(2). 218–227. 1 indexed citations
5.
Khan, Khaleque Newaz, Akira Fujishita, Akemi Koshiba, et al.. (2019). Biological differences between intrinsic and extrinsic adenomyosis with coexisting deep infiltrating endometriosis. Reproductive BioMedicine Online. 39(2). 343–353. 53 indexed citations
6.
Yoshida, Naohisa, Tetsuya Taguchi, Masayoshi Nakanishi, et al.. (2019). Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens. BMC Pharmacology and Toxicology. 20(1). 6–6. 4 indexed citations
7.
Khan, Khaleque Newaz, Kazuo Yamamoto, Akira Fujishita, et al.. (2019). Association between FOXP3+ regulatory T-cells and occurrence of peritoneal lesions in women with ovarian endometrioma and dermoid cysts. Reproductive BioMedicine Online. 38(6). 857–869. 18 indexed citations
8.
Khan, Khaleque Newaz, Akira Fujishita, Akemi Koshiba, et al.. (2018). Biological differences between focal and diffuse adenomyosis and response to hormonal treatment. Reproductive BioMedicine Online. 38(4). 634–646. 16 indexed citations
10.
Kataoka, Hiroaki, Toshihiko Mori, Takeshi Yamamoto, et al.. (2014). Outcome of fertility-sparing treatment with medroxyprogesterone acetate for atypical hyperplasia and endometrial carcinoma in young Japanese women.. PubMed. 35(1). 11–5. 6 indexed citations
11.
Mori, Toshihiko, Motoshi Sawada, Haruo Kuroboshi, et al.. (2014). Evaluation of primary prophylaxis with granulocyte colony-stimulating factor for epithelial ovarian cancer.. PubMed. 35(1). 48–51. 5 indexed citations
12.
Yoshida, Naohisa, Toyoshi Hosokawa, Takeshi Ishikawa, et al.. (2013). Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients. Journal of Oncology. 2013. 1–8. 26 indexed citations
13.
Mori, Taisuke, Morio Sawada, Haruo Kuroboshi, et al.. (2011). Estrogen-Related Receptor α Expression and Function Are Associated With Vascular Endothelial Growth Factor in Human Cervical Cancer. International Journal of Gynecological Cancer. 21(4). 609–615. 20 indexed citations
14.
Mori, Taisuke, et al.. (2011). Lymphoepithelial-like carcinoma of the uterine cervix; a case report.. PubMed. 32(3). 325–7. 6 indexed citations
15.
Mori, Taisuke, Morio Sawada, Haruo Kuroboshi, et al.. (2010). Neoadjuvant Weekly Carboplatin and Paclitaxel Followed by Radical Hysterectomy for Locally Advanced Cervical Cancer. International Journal of Gynecological Cancer. 20(4). 611–616. 28 indexed citations
16.
Ito, Kimihiko, Hiroshi Tsubamoto, Haruo Kuroboshi, et al.. (2010). A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: A Kansai Clinical Oncology Group study (KCOG0015 trial). Gynecologic Oncology. 120(2). 193–197. 8 indexed citations
17.
Mori, Taisuke, Yoshiyuki Kinoshita, Ai Watanabe, et al.. (2007). A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer. International Journal of Clinical Oncology. 12(3). 205–211. 12 indexed citations
18.
Kuroboshi, Haruo, Tomoharu Okubo, Kotaro Kitaya, et al.. (2003). Interferon regulatory factor-1 expression in human uterine endometrial carcinoma. Gynecologic Oncology. 91(2). 354–358. 13 indexed citations
19.
Nakayama, Takeshi, Kotaro Kitaya, Tomoharu Okubo, et al.. (2003). Fluctuation of 6Ckine expression in human endometrium during the menstrual cycle. Fertility and Sterility. 80(6). 1461–1465. 22 indexed citations
20.
Kitaya, Kotaro, Takeshi Nakayama, Tomoharu Okubo, et al.. (2003). Expression of Macrophage Inflammatory Protein-1β in Human Endometrium: Its Role in Endometrial Recruitment of Natural Killer Cells. The Journal of Clinical Endocrinology & Metabolism. 88(4). 1809–1814. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026